Meeting
2023 ASCO Annual Meeting
P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate and poor-risk metastatic germ cell tumours (GCTs).
Authors
Danka Sinikovic Zebic
NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia
Danka Sinikovic Zebic , Ben Tran , Andrew James Martin , Farzana D. Pashankar , Danish Mazhar , Robert A Huddart , Matthew Wheater , Euan Thomas Walpole , Elaine Dunwoodie , Darren R. Feldman , Alison Jane Birtle , David Wyld , Nicola Jane Lawrence , Martin R. Stockler , Peter S. Grimison
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Germ Cell/Testicular Cancer
Clinical Trial Registration Number
NCT02582697
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr TPS5102)
DOI
10.1200/JCO.2023.41.16_suppl.TPS5102
Abstract #
TPS5102
Poster Bd #
194a
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate- and poor-risk metastatic germ cell tumours (GCTs).
First Author: Danka Zebic
Poster
2019 Genitourinary Cancers Symposium
P3BEP (ANZUP 1302): An international randomized phase III trial of accelerated versus standard BEP chemotherapy for adult and pediatric male and female patients with intermediate and poor-risk metastatic germ cell tumors (GCTs).
First Author: Alison Yan Zhang
Poster
2018 ASCO Annual Meeting
P3BEP (ANZUP 1302): An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours (GCTs).
First Author: Peter S. Grimison
Poster
2018 Genitourinary Cancers Symposium
P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumors (GCTs).
First Author: Namrata Nayar